Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -6.85% is 79% above its 5-year average of -32.69%, near the high end of its 5-year range (-77.59%–-2.92%).
15.43% above its 12-month average of -8.10%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -7.30%.
NET PROFIT MARGIN
-6.85%
NET PROFIT MARGIN AVG TTM
-8.10%
NET PROFIT MARGIN AVG 3Y
-17.10%
NET PROFIT MARGIN AVG 5Y
-32.69%
NET PROFIT MARGIN AVG 10Y
-40.79%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+15.43%
CURRENT VS 3Y AVG
+59.95%
CURRENT VS 5Y AVG
+79.04%
CURRENT VS 10Y AVG
+83.20%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-1857.14%
vs the sector median at left
SI-BONE, Inc.
Market Cap
$867.03M
Net Profit Margin
-6.85%
TTM Avg
-8.10%
3Y Avg
-17.10%
5Y Avg
-32.69%
Market Cap
$870.81M
Net Profit Margin
-4994.86%
TTM Avg
-4994.86%
3Y Avg
-4994.86%
5Y Avg
-4994.86%
Market Cap
$857.16M
Net Profit Margin
-39.20%
TTM Avg
-57.59%
3Y Avg
-24.68%
5Y Avg
-1.42%
Market Cap
$855.38M
Net Profit Margin
-5933.45%
TTM Avg
-505.88%
3Y Avg
-252.94%
5Y Avg
-252.94%
Market Cap
$853.13M
Net Profit Margin
116.30%
TTM Avg
67.23%
3Y Avg
16.07%
5Y Avg
4.15%
Market Cap
$852.35M
Net Profit Margin
-173.85%
TTM Avg
-104.63%
3Y Avg
-54.62%
5Y Avg
-54.62%
Market Cap
$884.97M
Net Profit Margin
84.23%
TTM Avg
-685.46%
3Y Avg
-487.63%
5Y Avg
-594.40%
Market Cap
$887.50M
Net Profit Margin
9.36%
TTM Avg
-0.92%
3Y Avg
-15.83%
5Y Avg
-8.95%
Market Cap
$887.99M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SI-BONE, Inc. (SIBN) | $867.03M | -6.85% | -8.10% | -17.10% | -32.69% |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $870.81M | -4994.86% | -4994.86% | -4994.86% | -4994.86% |
| QuidelOrtho Corporation (QDEL)vs › | $857.16M | -39.20% | -57.59% | -24.68% | -1.42% |
| Alumis Inc. (ALMS)vs › | $855.38M | -5933.45% | -505.88% | -252.94% | -252.94% |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $853.13M | 116.30% | 67.23% | 16.07% | 4.15% |
| SL Science Holding Ltd (SLBT)vs › | $852.35M | -173.85% | -104.63% | -54.62% | -54.62% |
| Arbutus Biopharma Corp (ABUS)vs › | $884.97M | 84.23% | -685.46% | -487.63% | -594.40% |
| Bioventus Inc. (BVS)vs › | $887.50M | 9.36% | -0.92% | -15.83% | -8.95% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $887.99M | 0.00% | 0.00% | 0.00% | 0.00% |
| Pacific Biosciences of California, Inc. (PACB)vs › | $838.62M | -82.49% | -271.33% | -235.13% | -173.69% |
Operating Margin
-8.3%
Net Profit Margin
-6.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -7.30% |
| 2026-03-31 | -8.24% |
| 2025-12-31 | -2.92% |
| 2025-09-30 | -9.38% |
| 2025-06-30 | -12.65% |
| 2025-03-31 | -13.83% |
| 2024-12-31 | -9.17% |
| 2024-09-30 | -16.30% |
| 2024-06-30 | -22.36% |
| 2024-03-31 | -28.80% |
| 2023-12-31 | -28.26% |
| 2023-09-30 | -29.46% |
| 2023-06-30 | -33.65% |
| 2023-03-31 | -34.01% |
| 2022-12-31 | -34.97% |
| 2022-09-30 | -53.56% |
| 2022-06-30 | -72.36% |
| 2022-03-31 | -77.59% |
| 2021-12-31 | -57.38% |
| 2021-09-30 | -71.22% |
| 2021-06-30 | -62.99% |
| 2021-03-31 | -59.89% |
| 2020-12-31 | -40.55% |
| 2020-09-30 | -46.50% |
| 2020-06-30 | -88.78% |
| 2020-03-31 | -75.93% |
| 2019-12-31 | -45.92% |
| 2019-09-30 | -69.87% |
| 2019-06-30 | -53.04% |
| 2019-03-31 | -62.34% |
| 2018-12-31 | -33.99% |
| 2018-09-30 | -35.81% |
| 2018-06-30 | -23.03% |
| 2018-03-31 | -33.05% |
| 2017-12-31 | -35.62% |
| 2017-09-30 | -48.64% |
| 2017-06-30 | -52.79% |
| 2017-03-31 | -57.67% |
| 2016-03-31 | -69.26% |
| 2015-03-31 | -73.55% |
| 2014-12-31 | -80.13% |
| 2014-03-31 | -35.83% |
